PelvicEx
Biofeedback evidence

Pelvic-floor muscle training with vs without biofeedback for ED

Compare PFMT with and without biofeedback while preserving the evidence gap about biofeedback's added value for erectile dysfunction.

Published by 11min readUpdated:
On this page

Direct answer

For erectile dysfunction, evidence does not clearly establish how much biofeedback adds to pelvic-floor muscle training compared with well-taught PFMT alone. Current European guidance calls PFMT combined with biofeedback promising, but stronger trials are needed. That combined signal cannot prove that biofeedback is necessary, that any device works, or that unsupervised PFMT produces the same result.

Biofeedback may help some people understand a muscle action. It does not diagnose the cause of erectile difficulty or directly measure an erection outcome.

What biofeedback means in pelvic-floor care

Biofeedback turns a physiological signal into information a person and clinician can observe. Depending on the clinical setup, that signal may relate to electrical activity, pressure, movement, or another proxy for muscle behavior. The display might use a line, sound, number, or visual target.

The signal is not the muscle itself. It can be affected by sensor placement, surrounding muscle activity, movement, pressure, and equipment settings. Interpretation depends on what the system measures and why it is being used. A colorful graph does not automatically show a correct contraction, complete release, or useful sexual-function change.

Biofeedback is a teaching aid, not a separate muscle

PFMT can be taught through explanation, observation, palpation when consented to, functional cues, and practice review. Biofeedback adds another channel of information. It may be useful when a person cannot distinguish activation from release, substitutes other muscles, or benefits from seeing change over time.

Someone who already performs the intended action comfortably may gain little from an additional display. Someone with pain or guarding may need assessment and a different treatment direction rather than a target that encourages higher readings. The value depends on the question, not on device novelty.

What the erectile-dysfunction guideline says

The EAU guideline on erectile dysfunction describes PFMT combined with biofeedback as a promising option while calling for adequately powered, rigorously designed randomized trials. That is a statement of uncertainty. It is not a strong recommendation for a specific biofeedback protocol or product.

Because the intervention is combined, the observation cannot isolate whether benefit came from pelvic-floor practice, feedback, therapist contact, education, other treatment elements, or their interaction. It also cannot show that removing biofeedback would leave the same, smaller, or no effect.

What the systematic review adds

The 2019 systematic review found a positive PFMT signal for erectile dysfunction and premature ejaculation in selected adult male populations. Programmes varied in training content, supervision, co-interventions, and outcomes, and the evidence was low to moderate quality. The review did not establish one optimal protocol.

This heterogeneity prevents a clean “with versus without” verdict. A trial of supervised care with clinic equipment is not evidence for a consumer sensor used alone. A programme that includes lifestyle advice or another treatment cannot reveal the isolated contribution of its feedback screen.

Population boundaries

The review excluded major urological surgery and neurological injury. Its findings should not be applied automatically after prostatectomy, pelvic radiation, spinal injury, or neurological disease. These contexts can change sensation, motor control, healing, and the wider rehabilitation plan.

The evidence also does not tell us whether biofeedback is more useful for a person with reduced voluntary force, poor coordination, delayed release, pain, or no measurable pelvic-floor impairment. Those are different clinical findings and may require different goals.

What biofeedback may help a person learn

In an appropriate assessment-led programme, feedback may help answer narrow process questions: Did a signal change when the person attempted the intended action? Can they reduce unnecessary effort? Does the signal return toward its starting pattern after an attempt? Can the person reproduce a clinician-taught strategy without excessive substitution?

Even these interpretations need caution. The ICS assessment terminology distinguishes force, endurance, power, coordination, and relaxation. A single device channel is unlikely to represent every quality, and a higher value is not always the desired outcome.

What biofeedback cannot tell you

A pelvic-floor signal cannot identify vascular disease, diabetes, hormone change, nerve injury, medication effects, penile structural conditions, arousal, or psychological contributors to erectile dysfunction. It also cannot establish whether an erection is sufficiently firm or sustained for the person’s chosen activity unless that outcome is assessed separately.

Biofeedback does not turn a self-guided exercise into a medical diagnosis. It cannot prove that the pelvic floor caused the symptom, and it cannot guarantee that improving the displayed signal will improve erectile function.

Clinical systems and consumer devices are not interchangeable

Clinic equipment may be selected for a specific question, calibrated, placed by a trained professional, and interpreted alongside an examination. Consumer products can use different sensors, positions, algorithms, and proprietary scores. Marketing labels such as “strength,” “control,” or “performance” may not match validated clinical measurements.

Before using any device, ask what it measures, whether it has been studied for the intended population and outcome, how data are stored, and what happens if readings conflict with symptoms. Do not infer an erectile-dysfunction benefit from research in a different anatomy or in urinary incontinence.

Some feedback methods involve surface sensors; others may involve internal rectal sensors. An internal method is optional. The person can ask why it is proposed, request alternatives, decline, pause, or stop. Consent is ongoing and should never be treated as the price of receiving pelvic-health care.

Sexual-health data are sensitive. Device accounts, cloud dashboards, and shared reports can create privacy risks. A person should know who can access the information and should not be pressured to share it with a partner, advertiser, employer, or anyone outside their chosen care team.

When PFMT without biofeedback may be reasonable

PFMT without instrumentation may be reasonable when a qualified assessment supports a pelvic-floor goal, the person understands the intended action, practice is comfortable, and progress can be reviewed through clinical and functional outcomes. Direct clinician teaching can still be supervised even when no sensor is used.

Choosing no device is not choosing inferior care. The evidence does not establish that biofeedback is essential for ED. Cost, accessibility, privacy, sensory preferences, and willingness to use equipment are legitimate parts of shared decision-making.

When biofeedback may be worth discussing

A clinician may suggest feedback when uncertainty about activation or release is blocking rehabilitation, when repeated substitution is difficult to recognize, or when an objective teaching aid may improve understanding. The purpose should be explicit before equipment is used, and there should be a plan for applying the learning without dependence on the display.

If a person becomes preoccupied with scores, increases effort to chase a number, or experiences pain or urinary and bowel symptoms, the method should be reviewed. More signal is not automatically better.

ED assessment remains necessary

NIDDK guidance explains that erectile-dysfunction evaluation can include medical, sexual, and mental-health history, physical examination, and selected tests. Biofeedback addresses none of the full vascular, neurological, hormonal, structural, medication, or psychological work-up.

New or persistent erectile difficulty should therefore not be managed by purchasing a device first. A clinician can decide whether pelvic-floor rehabilitation belongs alongside medical, lifestyle, psychological, or other care.

How to judge usefulness

Judge biofeedback by whether it helps the person understand and carry out an agreed muscle goal comfortably—not by whether a score rises indefinitely. Separately review the chosen erectile-function outcome and any adverse effects. A device process metric should never be substituted for sexual wellbeing.

If the person improves while receiving several treatments, preserve uncertainty about which component helped. If there is no meaningful change, reconsider the diagnosis and plan instead of escalating device use.

PelvicEx is not a biofeedback device

PelvicEx can prepare and run an immutable session snapshot with timed phase cues and local outcome recording. It has no body sensor, does not receive muscle signals, does not measure contractions or erections, and cannot provide biofeedback or live technique verification. It also does not send workout reminders.

A PelvicEx preview cannot substitute for clinician-observed technique or a validated clinical instrument. It can only display the plan that has been prepared.

Safety and referral

Stop or pause practice if sensor use or contractions cause pain, bleeding, numbness, skin irritation, painful ejaculation, a persistent clenched feeling, or new difficulty urinating or emptying the bowel. Do not insert a device when contraindicated by recent surgery, active symptoms, or clinician instructions.

Seek assessment for ongoing erectile difficulty and for symptoms after pelvic trauma, treatment, or medication changes. Urgent evaluation is needed for sudden genital or saddle numbness with acute bladder, bowel, or leg neurological changes. This guide provides general education and cannot provide individual exercise clearance.

Read Kegel exercises for erection firmness and control for the underlying PFMT boundary. What an app can and cannot tell about the pelvic floor explains digital measurement limits. For broader ED care, see why PFMT is an adjunct, not a complete treatment.

Sources

  • European Association of Urology. “Management of Erectile Dysfunction.” Sexual and Reproductive Health Guideline. Current online edition. Official guideline.
  • Myers C, Smith M. “Pelvic floor muscle training improves erectile dysfunction and premature ejaculation: a systematic review.” Physiotherapy. 2019;105(2):235–243. PubMed record.
  • Frawley H, Shelly B, Morin M, et al. “An International Continence Society report on the terminology for pelvic floor muscle assessment.” Neurourology and Urodynamics. 2021;40(5):1217–1260. Official ICS report.
  • National Institute of Diabetes and Digestive and Kidney Diseases. “Diagnosis of Erectile Dysfunction.” Reviewed October 2024. NIDDK guidance.
Practise with care
This guide is for general education, not medical advice. Stop if an exercise causes pain and seek qualified guidance for questions about your symptoms.
Evidence and review
4 evidence records
Keep learning
See when assessment-led PFMT may be considered for erectile goals without a firmness, control, or performance guarantee.
Understand the difference between app-recorded behaviour and clinical pelvic-floor assessment, including technique, symptoms, diagnosis, and safety limits.
Place PFMT within a complete erectile-dysfunction assessment without presenting exercise as a cure or replacement for care.